February 2, 2018

Adjustment of EMA Pharmacovigilance fees for inflation | Adoption of the EU delegated act

European Union

Regulatory Pharma

The delegated act Adjustment of EMA Pharmacovigilance fees for inflation (Regulation (EU) No 658/2014) is now planned. It is based on Regulation (EU) No 658/2014 of the European Parliament and of the Council of 15 May 2014 on fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use Text with EEA relevance. For more information please consult the Register of Delegated Acts on https://webgate.ec.europa.eu/regdel/#/delegatedActs/740

Adjustment of EMA Pharmacovigilance fees for inflation | Adoption of the EU delegated act

Your substances

None

Related News

Automate your regulatory monitoring

or learn more about our plans

Adjustment of EMA Pharmacovigilance fees for inflation | Adoption of the EU delegated act

Your substances

None

Related News